支架市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品类型、生物材料、最终用户、地区和竞争细分

2022 年全球支架市场价值为 100.6 亿美元，预计在预测期内将出现令人印象深刻的成长，预计到 2028 年复合年增长率 (CAGR) 为 6.46%。

支架是一种小的网状管，用于保持体内狭窄或弱化通道（例如动脉）的通畅。它通常用于治疗已变窄的冠状动脉，从而减少对心臟的富氧血液的供应。将支架放置在体内的过程称为支架置入术。

支架的主要应用之一是恢復因斑块堆积而阻塞的血管中的血流。这种斑块通常由血液中的脂肪和胆固醇等物质组成。随着时间的推移，这种斑块会黏附在动脉壁上，并逐渐减少到达身体各部位的含氧血液量。斑块的积聚可导致冠心病的发展。

市场概况
预测期	2024-2028
2022 年市场规模	100.6亿美元
2028 年市场规模	147.7亿美元
2023-2028 年复合年增长率	6.46%
成长最快的细分市场	医院和诊所
最大的市场	北美洲

有斑块堆积的人可能会出现警讯，例如胸痛。如果不及时干预，他们将面临更高的併发症风险，包括中风或心臟病发作。为了防止动脉阻塞或过度狭窄，医疗保健提供者使用支架来促进不间断的血液流动。

主要市场驱动因素

慢性病盛行率增加

全球慢性病盛行率不断上升，大大推动了对支架的需求，支架是现代临床治疗的重要组成部分。冠状动脉疾病、週边动脉疾病和肾臟疾病等慢性疾病常导致血管变窄，阻碍血液的顺畅流动。支架，即用于治疗体内狭窄或弱化动脉的小网状管，为此问题提供了有效的解决方案。

糖尿病和肥胖病例的激增主要是由于久坐的生活方式和不健康的饮食习惯，导致血管疾病的发生率上升。这反过来又推动了支架置入手术的需求。此外，人口老化越来越容易罹患慢性病，这也增加了支架需求的动机。

为了满足这一不断增长的需求，医疗器材製造商正在专注于开发先进的支架，其特点是改进的设计、生物相容性和药物洗脱特性。微创外科手术的进步也促进了这些设备的采用。鑑于支架在应对慢性疾病中发挥的这些不可或缺的作用，预计支架的需求将继续呈上升趋势。这使得支架成为全球医疗保健策略的焦点，特别强调提高其有效性、可近性和可负担性。

老年人口增加

随着个体年龄的增长，罹患冠状动脉疾病（CAD）和周边动脉疾病（PAD）等心血管疾病的风险显着增加。支架是一种重要的医疗设备，用于透过重新打开阻塞或狭窄的动脉、改善血流并预防心臟病和中风等严重併发症来治疗这些疾病。老年人经常患有多种慢性健康问题，包括糖尿病和高血压，这些疾病会加速动脉粥状硬化的发生和进展。支架经常用于透过保持血管通畅来解决这些病症的后果。支架技术的持续研究和开发催生了更先进和创新的设备。例如，药物洗脱支架释放药物以降低所治疗动脉再狭窄或重新狭窄的风险。这些技术进步提高了支架手术的有效性和安全性，使其更适合老年患者。

支架置入通常透过微创手术进行，这通常是可能有其他健康问题的老年患者的首选。与传统的开放性手术相比，这些手术可以提供更快的恢復时间并减少术后併发症。老年人口的增加是支架需求不断增长的重要驱动力。随着老年人更容易患心血管疾病和其他慢性健康状况，对支架植入等介入手术的需求预计会增加。创新支架技术和微创技术的发展进一步支持支架的利用来满足老年人的医疗保健需求，最终提高他们的整体生活品质和寿命。

支架开发的技术进步

医疗保健领域对先进技术的需求不断增长，导致市场对支架的需求大幅增加。随着越来越多的老年人需要医疗干预，支架已成为满足其医疗保健需求的重要组成部分。此外，更高的可支配收入使个人能够选择尖端技术和设备，以在外科手术后提供更好的结果。

这些最先进技术的利用增强了潜在消费者的信心，确保他们相信手术程序和技术的有效性和可靠性。这不仅提高了患者满意度，也有助于支架市场的整体成长。此外，疫情爆发后的最新进展，例如创新支架设计和材料的开发，进一步促进了支架市场的扩张。

这些发展为这一关键医疗领域的成长和创新创造了新的机会，为支架技术的进步铺平了道路，以满足患者和医疗保健提供者不断变化的需求。随着对先进医疗解决方案的需求持续增长，支架市场有望进一步扩大和进步，在改善患者治疗效果和提高医疗品质方面发挥着至关重要的作用。

对外科手术的需求不断增加

近年来，利用微创技术的先进外科手术的需求明显且逐渐增加。这些尖端方法彻底改变了手术领域，为患者提供了侵入性较小的选择和更快的恢復时间。特别受益于这些进步的一个领域是心血管外科。现代设备和装置的引入极大地提高了心血管系统相关外科手术的成功率和结果。特别是支架的使用已变得越来越普遍，为因高胆固醇水平引起的严重阻塞的患者提供了有效的解决方案。

老年人口的偏好进一步刺激了对手术介入的需求。由于等待药物起效的时间有限，许多老年患者选择外科手术作为治疗心血管疾病的更直接的解决方案。对外科手术介入的需求不断增长，为预测期内的市场成长提供了重大机会。随着全球患有严重心血管疾病的人数持续增加，先进外科手术及相关产品的市场可望长期扩张。总体而言，这些趋势凸显了微创手术领域持续创新的必要性以及病患照护和结果显着进步的潜力。

主要市场挑战

不利的政府法规

与现代技术发展直接相关的众多规则和法规严重阻碍了支架市场的成长。政府实施的这些法规为市场的扩张带来了重大挑战和障碍。不利的政府法规和指导方针不仅在短期内影响了市场，而且从长远来看也有可能阻碍其成长。

遇到这些障碍的关键领域之一是保险范围。有关支架手术保险范围的规定使一般民众难以取得和负担这些现代技术。此外，税收负担进一步增加了寻求支架治疗的个人面临的财务挑战。由于政府实施的复杂的法规和指导方针，支架市场面临重大障碍。这些障碍不仅限制了市场的成长潜力，也限制了那些可以从中受益的人获得现代科技的机会。

高产品召回率

由于安全问题而召回的支架削弱了患者对这些设备的有效性和安全性的信心。当患者和医疗保健提供者认为与支架相关的风险较高时，他们可能会选择替代治疗或方法，导致需求减少。多次召回往往会引起监管机构的注意，促使对支架製造和品质控制流程进行更严格的监督。虽然这对于患者安全至关重要，但它可能导致产品批准和市场推出的延迟，限制支架的可用性并减少需求。高调的召回可能会产生负面宣传，从而进一步削弱大众对支架产品的信任。这种看法会影响患者的决定并降低他们接受支架手术的意愿，即使有医学指征。

支架行业的大量产品召回创造了一个充满挑战的环境，其特点是患者信任度下降、监管审查和竞争加剧。这些因素共同导致了支架手术和产品需求的减少，凸显了严格的品质控制和安全措施对于维持支架製造商在医疗保健市场的信誉和生存能力的重要性。

主要市场趋势

非侵入性手术选项

对微创手术和管理的需求不断增长，显着增加了对先进支架的需求，这对于支持和改善患者的治疗效果至关重要。这些创新的医疗设备在提供有效的治疗选择且对身体的干扰最小化方面发挥着至关重要的作用。

微创手术已被证明对癒合过程非常有益，可以使患者更快康復并减少术后併发症。然而，值得注意的是，这些手术通常需要较长的持续时间才能确保最佳结果并促进完全康復。相较之下，非侵入性外科手术已成为患者（尤其是糖尿病患者）的一种有前途的替代方案。这些程序提供更快的癒合和恢復时间，使患者能够更快地恢復健康和福祉。

医疗保健领域对现代技术的需求不断增长，为支架市场的成长创造了绝佳的机会。随着医疗保健提供者和患者都寻求先进的解决方案和改善的结果，全球对尖端支架的需求持续增长。这个不断增长的市场呈现出巨大的创新和发展潜力，推动医疗保健行业加强患者护理并提高生活品质。

不健康的生活方式和久坐的习惯

由于现代生活方式和久坐习惯，人们的整体健康状况严重恶化。患者心血管疾病的增加令人震惊，并且随着时间的推移而迅速增加。为了解决这个关键问题，患有严重阻塞的患者需要使用先进的支架，不仅提供有效的治疗，而且对市场的成长做出了重大贡献。

此外，紧张的工作日程和忙碌的生活方式的普遍性对个人的心臟健康产生了深远的影响。这一新兴趋势为支架市场的扩展和满足对创新解决方案日益增长的需求提供了重大机会。透过满足患者的特定需求并提供先进的支架技术，该市场可以在改善整体心臟健康和提高许多人的生活品质方面发挥至关重要的作用。

细分市场洞察

生物材料见解

根据生物材料，市场分为金属生物材料、聚合物生物材料和天然生物材料。 2022年，金属生物材料领域已成为市场的主导力量。随着心血管疾病支架的生产成为重点，该行业的製造商正在积极加强。随着内视镜检查和透视病例的增加，这些金属支架的使用预计将出现显着激增。

此外，预计聚合物生物材料领域的成长轨迹也将在未来几年获得成长动能。对聚合物支架的需求大幅上升，这主要是由于心血管疾病病例的不断增加。此外，政府对此类支架的认可度不断提高，进一步提振了市场前景，预示着该领域的广阔前景。

最终使用者见解

根据最终用户，医院部分已成为最大的部分，因为大多数程序都是在医院设置内进行的。医院设施为患者和医务人员提供广泛的设施，为进行外科手术创造有利的环境。医院拥有最先进的设备和专业的医疗保健专业人员团队，可确保在这些手术过程中提供最高水准的护理和安全。

此外，在整个手术过程中密切监测患者的其他重要参数非常重要，这可以在设备齐全的医院环境中有效地完成。这种持续监测有助于发现任何潜在的併发症或偏差，以便及时介入并确保患者获得最佳结果。除医院外，门诊手术中心领域预计也将显着成长。这些中心在门诊提供专业手术服务，为患者提供便利和成本效益。随着医疗技术的进步和对微创手术的需求不断增加，门诊手术中心正在成为医疗保健领域不可或缺的一部分。

总体而言，医院内多种设施的可用性和门诊手术中心的兴起有助于手术治疗的成长和扩大，确保患者在合适的医疗环境中获得最高品质的照护。

区域洞察

根据地理分析，北美地区已成为最大的支架市场，因为该地区居住着大量患者。北美人口中有很大一部分属于老年人，导致久坐的生活方式和心血管疾病发生率的增加。由于老年人癒合能力较弱，对微创外科手术的需求不断增长，促进了支架市场的快速扩张。此外，现代生活方式和久坐习惯导致胆固醇水平上升，导致心腔发生严重阻塞，需要进行手术治疗。医院拥有最先进的医疗设施，进一步扩大了该地区的市场。

同样，由于政府提供先进的医疗服务，欧洲地区的支架市场也不断成长。欧洲人口对现代医疗保健服务的利用导致了对先进手术选择和尖端设备使用的需求。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球支架市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型（药物洗脱支架、裸金属冠状动脉支架及生物可吸收支架）
  • 依生物材料（金属生物材料、高分子生物材料及天然生物材料）
  • 按最终使用者（医院和诊所、门诊手术中心、其他）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美支架市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 透过生物材料
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲支架市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 透过生物材料
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太支架市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 透过生物材料
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲支架市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 透过生物材料
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第10章：中东和非洲支架市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 透过生物材料
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非支架
  • 沙乌地阿拉伯支架
  • 阿联酋支架

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球支架市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 服务内容
• 最近的发展
• 主要人员
• SWOT分析
  • Medtronic plc
  • B. Braun Melsungen AG
  • Terumo Corporation
  • STENTYS SA
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • Translumina GmbH
  • Biosensors International Group Limited
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG

第 16 章：策略建议

第 17 章：关于我们与免责声明

The Global Stent Market, valued at USD 10.06 Billion in 2022, is poised for impressive growth in the forecast period, with an anticipated Compound Annual Growth Rate (CAGR) of 6.46% through 2028.

A stent is a small, mesh-like tube utilized to maintain the patency of narrowed or weakened passages within the body, such as arteries. It is commonly employed in the treatment of coronary arteries that have become narrowed, thereby reducing the supply of oxygen-rich blood to the heart. The procedure of placing a stent within the body is known as stenting.

One of the primary applications of stents is to restore blood flow in vessels that have become obstructed due to the accumulation of plaque. This plaque typically consists of substances like fat and cholesterol found in the bloodstream. Over time, this plaque adheres to the walls of the arteries, gradually diminishing the amount of oxygenated blood reaching various parts of the body. The buildup of plaque can lead to the development of coronary heart disease.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 10.06 Billion
Market Size 2028	USD 14.77 Billion
CAGR 2023-2028	6.46%
Fastest Growing Segment	Hospitals & Clinics
Largest Market	North America

Individuals with plaque buildup may experience warning signs, such as chest pain. Without timely intervention, they face an increased risk of complications, including stroke or heart attack. To prevent arterial blockage or excessive narrowing, healthcare providers employ stents, which facilitate uninterrupted blood flow.

Stents come in various types, most commonly made from a mesh-like material of either plastic or metal. However, in larger arteries, stent grafts, composed of fabric, are used. Additionally, some stents are coated with medications to prevent the closure of the obstructed artery, promoting long-term patency.

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases worldwide is significantly driving the demand for stents, a vital component of modern clinical therapeutics. Chronic conditions such as coronary artery disease, peripheral artery disease, and kidney diseases often result in the narrowing of blood vessels, obstructing the smooth flow of blood. Stents, small mesh tubes that are used to treat narrowed or weakened arteries in the body, present an effective solution to this problem.

The surge in cases of diabetes and obesity, primarily due to sedentary lifestyles and unhealthy eating habits, is contributing to an upswing in vascular diseases. This, in turn, is propelling the need for stenting procedures. Moreover, the aging population is increasingly susceptible to chronic diseases, adding to the impetus for stent demand.

In a bid to meet this burgeoning demand, medical device manufacturers are focusing on the development of advanced stents, characterized by improved designs, biocompatibility, and drug-eluting properties. The advancements in minimally invasive surgical procedures are also boosting the adoption of these devices. In light of these integral roles that stents play in responding to chronic diseases, it is anticipated that the demand of stents to continue on an upward trajectory. This makes stents a focal point in healthcare strategies globally, with a particular emphasis on enhancing their effectiveness, accessibility, and affordability.

Increasing Geriatric Population

As individuals age, their risk of developing cardiovascular diseases such as coronary artery disease (CAD) and peripheral arterial disease (PAD) significantly increases. Stents are a crucial medical device used to treat these conditions by reopening blocked or narrowed arteries, improving blood flow, and preventing serious complications like heart attacks and strokes. The elderly often contends with multiple chronic health conditions, including diabetes and hypertension, which can accelerate the development and progression of atherosclerosis. Stents are frequently employed to address the consequences of these conditions by maintaining the patency of blood vessels. Ongoing research and development in stent technology have led to the creation of more advanced and innovative devices. Drug-eluting stents, for instance, release medication to reduce the risk of restenosis or re-narrowing of the treated artery. These technological advancements have improved the efficacy and safety of stent procedures, making them more suitable for older patients.

Stent placement is typically performed through minimally invasive procedures, which are often preferred for older patients who may have additional health concerns. These procedures offer quicker recovery times and reduce post-operative complications compared to traditional open surgeries. The increasing geriatric population is a significant driver behind the rising demand for stents. As older individuals become more susceptible to cardiovascular diseases and other chronic health conditions, the need for interventional procedures like stent implantation is expected to grow. The development of innovative stent technologies and minimally invasive techniques further supports the utilization of stents in addressing the healthcare needs of the elderly, ultimately improving their overall quality of life and longevity.

Technological Advancements in Stent Development

The growing demand for advanced technology in the field of medical science and healthcare has led to a significant boost in the demand for stents in the market. With an increasing number of individuals from the geriatric age group requiring medical intervention, stents have become a crucial component in addressing their healthcare needs. Moreover, the availability of higher disposable income has empowered individuals to opt for cutting-edge technologies and equipment that provide superior outcomes following surgical procedures.

The utilization of these state-of-the-art technologies has instilled confidence in potential consumers, assuring them of the effectiveness and reliability of surgical procedures and techniques. This not only enhances patient satisfaction but also contributes to the overall growth of the stent market. Furthermore, the recent advancements witnessed in the wake of the pandemic outbreak, such as the development of innovative stent designs and materials, have further contributed to the expansion of the stent market.

These developments have created new opportunities for growth and innovation in this crucial medical field, paving the way for advancements in stent technology to meet the evolving needs of patients and healthcare providers alike. As the demand for advanced medical solutions continues to rise, the stent market is poised for further expansion and progress, playing a vital role in improving patient outcomes and enhancing the quality of healthcare.

Increasing Demand for Surgical Procedures

In recent years, there has been a noticeable and gradual increase in the demand for advanced surgical procedures that utilize minimally invasive techniques. These cutting-edge methods have revolutionized the field of surgery, providing patients with less invasive options and faster recovery times. One area that has particularly benefited from these advancements is cardiovascular surgery. The introduction of modern equipment and devices has greatly improved the success rates and outcomes of surgical procedures related to the cardiovascular system. In particular, the use of stents has become increasingly common, offering effective solutions for patients suffering from severe blockages caused by high cholesterol levels.

The demand for surgical interventions is further fueled by the preferences of the geriatric population. With limited time to wait for the effects of medications, many older patients opt for surgical procedures as a more immediate solution to their cardiovascular conditions. This growing demand for surgical interventions presents a significant opportunity for market growth in the forecast period. As the number of people worldwide suffering from severe cardiovascular diseases continues to rise, the market for advanced surgical procedures and related products is poised for long-term expansion. Overall, these trends highlight the need for continuous innovation in the field of minimally invasive surgery and the potential for significant advancements in patient care and outcomes.

Key Market Challenges

Unfavorable Government Regulations

The growth of the stent market has been significantly hindered by numerous rules and regulations that are directly associated with the development of modern technologies. These regulations, imposed by the government, have posed major challenges and obstacles to the market's expansion. The unfavorable government regulations and guidelines have not only affected the market in the short term but also have the potential to impede its growth in the long run.

One of the key areas where these obstacles have been experienced is in terms of insurance coverage. The regulations surrounding insurance coverage for stent procedures have made it difficult for common people to access and afford these modern technologies. Additionally, the burden of taxes further adds to the financial challenges faced by individuals seeking stent treatment. The stent market faces significant hurdles due to the complex web of regulations and guidelines imposed by the government. These barriers not only limit the growth potential of the market but also restrict the accessibility of modern technologies for those who could benefit from them.

High Product Recalls

Recalls of stents due to safety issues erode patient confidence in the effectiveness and safety of these devices. When patients and healthcare providers perceive a higher risk associated with stents, they may opt for alternative treatments or approaches, leading to reduced demand. Repeated recalls often attract the attention of regulatory authorities, prompting more rigorous oversight of stent manufacturing and quality control processes. While this is essential for patient safety, it can lead to delays in product approvals and market launches, limiting the availability of stents and reducing demand. High-profile recalls can generate negative publicity, which can further erode public trust in stent products. This perception can influence patients' decisions and reduce their willingness to undergo stent procedures, even when medically indicated.

High product recalls in the stent industry have created a challenging environment, characterized by decreased patient trust, regulatory scrutiny, and increased competition. These factors collectively contribute to the diminishing demand for stent procedures and products, underscoring the importance of rigorous quality control and safety measures to maintain the credibility and viability of stent manufacturers in the healthcare market.

Key Market Trends

Non-Invasive Procedures Options

The increasing demand for minimally invasive surgical procedures and management has significantly boosted the demand for advanced stents, which are crucial in supporting and enhancing patient outcomes. These innovative medical devices play a vital role in providing effective treatment options with minimal disruption to the body.

Minimally invasive surgical procedures have proven to be highly beneficial for the healing process, allowing patients to recover faster and experience reduced post-operative complications. However, it is worth noting that these procedures often require a longer duration to ensure optimal results and promote complete recovery. In contrast, non-invasive surgical procedures have emerged as a promising alternative for patients, particularly those with diabetes. These procedures offer faster healing and recovery times, empowering patients to regain their health and well-being more rapidly.

The increasing demand for modern technologies in the healthcare sector has created a remarkable opportunity for the growth of the stents market. With healthcare providers and patients alike seeking advanced solutions and improved outcomes, the demand for cutting-edge stents continues to rise globally. This growing market presents immense potential for innovation and development, driving the healthcare industry towards enhanced patient care and improved quality of life.

Unhealthy Lifestyle and Sedentary Habits

As a result of modern lifestyle practices and sedentary habits, the overall health of people has severely deteriorated. The rise in cardiovascular disorders among patients has been alarming, with a rapid increase over time. In order to address this critical issue, patients with major blockages require the utilization of advanced stents, which not only provide effective treatment but also contribute significantly to the growth of the market.

Furthermore, the prevalence of a stressful work schedule and busy lifestyle has had a profound impact on the cardiac health of individuals. This emerging trend presents a significant opportunity for the stent market to expand and cater to the increasing demand for innovative solutions. By addressing the specific needs of patients and offering advanced stent technologies, the market can play a vital role in improving overall cardiac health and enhancing the quality of life for many individuals.

Segmental Insights

Biomaterial Insights

Based on the biomaterial, the market is segmented into metallic biomaterial, polymeric biomaterial, and natural biomaterial. In 2022, the Metallic Biomaterial segment has emerged as the dominant force in the market. With a sharp focus on the production of stents for cardiovascular diseases, manufacturers in this industry are proactively increasing their efforts. The utilization of these metallic stents is projected to witness a notable surge alongside the rise in endoscopy and fluoroscopy cases.

Furthermore, the growth trajectory of the polymeric bio-materials segment is also anticipated to gain momentum in the upcoming years. The demand for polymeric stents has witnessed a significant upswing, largely driven by the escalating cases of cardiovascular diseases. Moreover, the government's increasing approval of this type of stent further bolsters market prospects, indicating a promising future for this segment.

End User Insights

Based on the end user, the segment of the hospital has emerged as the largest segment as most of the procedures are carried out within a hospital setup. A hospital setup provides a wide range of facilities to both patients and medical staff, creating a conducive environment for carrying out surgical procedures. With state-of-the-art equipment and a dedicated team of healthcare professionals, hospitals ensure the highest level of care and safety during these procedures.

Furthermore, it is extremely essential to closely monitor the other vital parameters of the patient throughout the procedure, which can be efficiently done within a well-equipped hospital setup. This constant monitoring helps in detecting any potential complications or deviations, allowing for timely intervention and ensuring the best possible outcomes for the patients. In addition to hospitals, the ambulatory surgical center segment is also expected to witness significant growth. These centers offer specialized surgical services on an outpatient basis, providing convenience and cost-effectiveness to patients. With advancements in medical technology and increasing demand for minimally invasive procedures, ambulatory surgical centers are becoming an integral part of the healthcare landscape.

Overall, the availability of multiple facilities within hospitals and the rise of ambulatory surgical centers contribute to the growth and expansion of surgical treatments, ensuring that patients receive the highest quality care in a suitable healthcare setting.

Regional Insights

Based on geographical analysis, the North America region has emerged as the largest market for stents, attributable to the substantial patient population residing in this area. A significant portion of the North American population falls within the geriatric age group, leading to sedentary lifestyles and an increased incidence of cardiovascular diseases. The growing demand for minimally invasive surgical procedures, fueled by the weak healing capacity of the geriatric population, has contributed to the rapid expansion of the stents market. Furthermore, the rising cholesterol levels resulting from modern lifestyle practices and sedentary habits have led to the occurrence of severe blockages in the heart's lumen, necessitating surgical management. The availability of state-of-the-art healthcare facilities in hospitals has further augmented the market in this region.

Similarly, the European region has witnessed a growing market for stents due to the advanced healthcare services provided by the government. The European population's utilization of modern healthcare services has led to a demand for advanced surgical options and the utilization of cutting-edge equipment.

Key Market Players

• Medtronic plc

• B. Braun Melsungen AG

• Terumo Corporation

• STENTYS SA

• MicroPort Scientific Corporation

• Meril Life Sciences Pvt. Ltd

• Translumina GmbH

• Biosensors International Group Limited

• Boston Scientific Corporation

• BIOTRONIK SE & Co. KG

Report Scope:

In this report, the Global Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Stent Market, By Product Type:

• Drug-Eluting Stent
• Bare Metal Coronary Stent
• Bioabsorbable Stent

Stent Market, By Biomaterial:

• Metallic Biomaterial
• Polymeric Biomaterial
• Natural Biomaterial

Stent Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgical Centres
• Others

Stent Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Stent Market.

Available Customizations:

• Global Stent market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Stent Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, and Bioabsorbable Stent)
  • 5.2.2. By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, and Natural Biomaterial)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map

6. North America Stent Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Biomaterial
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Stent Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Biomaterial
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Stent Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Biomaterial
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Stent Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Biomaterial
      • 6.3.3.2.3. By End User

7. Europe Stent Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Biomaterial
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Stent Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Biomaterial
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Stent Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Biomaterial
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Stent Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Biomaterial
      • 7.3.3.2.3. By End User
  • 7.3.4. France Stent Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Biomaterial
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Stent Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Biomaterial
      • 7.3.5.2.3. By End User

8. Asia-Pacific Stent Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Biomaterial
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Stent Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Biomaterial
      • 8.3.1.2.3. By End User
  • 8.3.2. India Stent Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Biomaterial
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Stent Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Biomaterial
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Stent Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Biomaterial
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Stent Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Biomaterial
      • 8.3.5.2.3. By End User

9. South America Stent Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Biomaterial
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Stent Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Biomaterial
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Stent Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Biomaterial
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Stent Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Biomaterial
      • 9.3.3.2.3. By End User

10. Middle East and Africa Stent Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Biomaterial
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Stent Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Biomaterial
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Stent Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Biomaterial
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Stent Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Biomaterial
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Stent Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Medtronic plc
  • 15.5.2. B. Braun Melsungen AG
  • 15.5.3. Terumo Corporation
  • 15.5.4. STENTYS SA
  • 15.5.5. MicroPort Scientific Corporation
  • 15.5.6. Meril Life Sciences Pvt. Ltd
  • 15.5.7. Translumina GmbH
  • 15.5.8. Biosensors International Group Limited
  • 15.5.9. Boston Scientific Corporation
  • 15.5.10. BIOTRONIK SE & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer